Recent publications · Crossref
5 total works indexed
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
· 2018 · cited 4,044x
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
· 2019 · cited 2,987x
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
· 2019 · cited 2,922x
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
· 2018 · cited 1,829x
- Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
· 2007 · cited 1,828x
via Crossref · CC0